ClearCogni Ingredients 2026 Review Finds Mixed Dosage Evidence

ClearCogni Ingredients 2026, a dietary supplement marketed for memory, focus, and mental clarity, has been the subject of a detailed review by a wire service editor. The supplement, produced by FlowOptiNutri, contains a blend of five active ingredients: Branched Chain Amino Acids (BCAAs), Bacopa Monnieri, Rhodiola Rosea, L-Theanine, and Panax Ginseng. Each serving of two capsules provides 540 mg of BCAAs, 200 mg of Bacopa Monnieri, 100 mg of Rhodiola Rosea, 100 mg of L-Theanine, and 90 mg of Panax Ginseng.

The supplement is positioned as a daily support formula for cognitive functions, but the review highlights that the ingredient dosages do not always match those used in the cited research studies. For instance, the L-Theanine dose in ClearCogni is 100 mg, while a 2026 systematic review and meta-analysis found significant attention benefits from a 200 mg dose. Similarly, the Bacopa Monnieri dose is 200 mg, whereas a 12-week, placebo-controlled trial used 300 mg. The Panax Ginseng dose is 90 mg, which is below the 200 mg to 400 mg range used in individual trials.

BCAAs, while commonly associated with exercise recovery, are included in the formula. A recent pilot study found that BCAAs paired with an exercise program improved physical performance and reduced fatigue in older adults, but the effect in a sedentary context is less clear.

Rhodiola Rosea, another ingredient, has mixed evidence. Some placebo-controlled trials found improvements in stress-related mental fatigue, while others reported no significant effects. The specific extract used by ClearCogni is not specified, which limits the ability to confirm its efficacy.

L-Theanine, one of the more consistent ingredients, has been shown to improve choice reaction time and reduce acute stress. However, the 200 mg dose used in the reviewed studies is double the 100 mg dose in ClearCogni.

Panax Ginseng, the final ingredient, has a mixed body of evidence. A Cochrane review found no convincing evidence of a cognitive-enhancing effect in healthy adults, though individual trials showed modest, dose-dependent results. The exact extract and dose used by ClearCogni are not specified, which further limits the application of the research findings.

The supplement is available in three pricing tiers: Basic (2 bottles, 60-day supply for $158), Most Popular (3 bottles, 90-day supply for $207), and Best Value (6 bottles, 180-day supply for $294). Each bottle contains 60 capsules, and the suggested use is two capsules daily with an 8-ounce glass of water, taken 20 to 30 minutes before a meal or as directed by a healthcare professional.

The review concludes that while the individual ingredients have some research backing, the specific dosages in ClearCogni do not always align with the more favorable studies. Therefore, the effectiveness of the formula in producing the advertised cognitive benefits remains uncertain. Consumers are advised to carefully consider the ingredient research and the specific dosages before deciding whether to purchase the product.